[
    [
        {
            "time": "2018-07-15",
            "original_text": "看好评级医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注意稳健成长和“流量入口”型公司",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报业绩",
                    "医疗需求",
                    "稳健成长",
                    "流量入口"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "看好评级医药生物行业2018年中报业绩前瞻：医疗需求刚性 重点关注意稳健成长和“流量入口”型公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-16",
            "original_text": "医药行业卓越推：华兰生物(002007)、天坛生物(600161)",
            "features": {
                "keywords": [
                    "华兰生物",
                    "天坛生物",
                    "卓越推荐"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业卓越推：华兰生物(002007)、天坛生物(600161)",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-17",
            "original_text": "推荐评级医药生物行业中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报业绩",
                    "二季度增速",
                    "个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "推荐评级医药生物行业中报业绩前瞻：重点覆盖公司中报业绩前瞻：关注2季度增速加快个股",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-18",
            "original_text": "两大逻辑促疫苗股飙升 4只白马股备受机构青睐",
            "features": {
                "keywords": [
                    "疫苗股",
                    "白马股",
                    "机构青睐"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两大逻辑促疫苗股飙升 4只白马股备受机构青睐",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-19",
            "original_text": "2018年H1血液制品批签发专题报告：行业转型期 资源与终端并重",
            "features": {
                "keywords": [
                    "血液制品",
                    "批签发",
                    "行业转型",
                    "资源与终端"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2018年H1血液制品批签发专题报告：行业转型期 资源与终端并重",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-07-20",
            "original_text": "两大逻辑促疫苗股飙升 6只白马股备受机构青睐",
            "features": {
                "keywords": [
                    "疫苗股",
                    "白马股",
                    "机构青睐"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两大逻辑促疫苗股飙升 6只白马股备受机构青睐",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-07-21",
            "original_text": "医药行业周报:《我不是药神》引热议 持续看好创新药板块",
            "features": {
                "keywords": [
                    "我不是药神",
                    "创新药",
                    "热议"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业周报:《我不是药神》引热议 持续看好创新药板块",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]